SCYNEXIS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SCYNEXIS, Inc. on September 18, 2018. The company is incorporated in Delaware and identifies as an emerging growth company. The report addresses a specific corporate governance event rather than periodic financial results.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a personnel change and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the resignation of Marion McCourt from the Board of Directors, effective immediately on September 18, 2018. Ms. McCourt had served on the Board since 2017. The resignation was attributed to time commitments associated with her role as Senior Vice President and Head of Commercial at Regeneron Pharmaceuticals, Inc.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific risk factors. The only contingency noted is the immediate vacancy on the Board of Directors resulting from the resignation.
Key Facts for Investors to Verify
- Confirmation of the immediate resignation of Director Marion McCourt.
- Whether the Board has initiated a search for a replacement director.
- Any potential impact on the company's strategic direction given Ms. McCourt's background in commercial operations.